BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 6, 2013
View Archived Issues
Disappointing results presented for linsitinib in phase II SCLC trial
Read More
Gender-specific modulation of hormone receptor activity to treat neurodegenerative disorders
Read More
Preclinical characteristics of uridine nucleotide prodrug IDX-30963 described
Read More
Cancer Research Technology and Nuevolution form collaboration to discover anticancer drug molecules
Read More
Ignyta completes merger and signs license agreement for tyrosine kinase inhibitors
Read More
Sanofi reflects on accomplishments of third quarter 2013
Read More
The Myelin Repair Foundation forms partnership with Bionure
Read More
Curemark begins rolling NDA submission for CM-AT
Read More
ND-654 and ND-630 evaluated for liver cancer and steatohepatitis
Read More
CureVac collaborates with the Cancer Research Institute and Ludwig Cancer Research
Read More
Roche discloses new CYP11B1/CPY11B2 inhibitors
Read More
Korean researchers prepare new DGAT1 inhibitors
Read More
Polyphor and Roche to develop therapeutic for multidrug-resistant bacterial infections
Read More
3pRNA RIG-I agonist displays activity against melanoma
Read More
Hookipa Biotech closes series B financing round to support product development
Read More
siRNA therapeutics targeted for AIP
Read More
RNA-based adjuvant demonstrates potent boosting in vivo
Read More
Shire provides topline results from pivotal phase III trials of Vyvanse in binge eating disorder
Read More
Researchers to conduct a phase I trial of a human monoclonal antibody for Hendra virus
Read More
First-in-human study of a therapeutic protein derived from CAP cells shows promise
Read More
RepliCel forms clinical advisory board to support the development of RCT-01
Read More
ImmunoGen discontinues IMGN-901 study in small-cell lung cancer
Read More
Endo Health Solutions to acquire Paladin Labs
Read More
Noven Pharmaceuticals launches Brisdelle in the U.S.
Read More
Bristol-Myers Squibb submits NDA in Japan for interferon- and ribavirin-free regimen for HCV
Read More
Gruenenthal patents new agents activating voltage-gated potassium channels
Read More
Glenmark Pharmaceuticals synthesizes novel MPGES-1 inhibitors
Read More